Global Addictions Therapeutics Market Growth (Status and Outlook) 2025-2031

September 2025 | 84 pages | ID: G9B89EF1534AEN
LP Information

Abstracts

According to this study, the global Addictions Therapeutics market size will reach US$ 6817 million by 2031.

Addiction is a brain disorder characterized by compulsive engagement in rewarding stimuli despite adverse consequences.Despite the involvement of a number of psychosocial factors, a biological process – one which is induced by repeated exposure to an addictive stimulus – is the core pathology that drives the development and maintenance of an addiction.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Addictions Therapeutics Industry Forecast” looks at past sales and reviews total world Addictions Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Addictions Therapeutics sales for 2025 through 2031. With Addictions Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Addictions Therapeutics industry.

This Insight Report provides a comprehensive analysis of the global Addictions Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Addictions Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Addictions Therapeutics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Addictions Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Addictions Therapeutics.

This report presents a comprehensive overview, market shares, and growth opportunities of Addictions Therapeutics market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Alcohol Addiction Therapeutics
• Tobacco Addiction Therapeutics
• Drug Addiction Therapeutics

Segmentation by Application:

• Public
• Private
• Government

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Alkermes Plc
• Amneal Pharmaceuticals Inc.
• Indivior Plc
• Johnson & Johnson Services Inc.
• Mylan NV
• Novartis AG
• Novo Nordisk AS
• Opiant Pharmaceuticals Inc.
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Addictions Therapeutics Market Size (2020-2031)
  2.1.2 Addictions Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Addictions Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 Addictions Therapeutics Segment by Type
  2.2.1 Alcohol Addiction Therapeutics
  2.2.2 Tobacco Addiction Therapeutics
  2.2.3 Drug Addiction Therapeutics
2.3 Addictions Therapeutics Market Size by Type
  2.3.1 Addictions Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Addictions Therapeutics Market Size Market Share by Type (2020-2025)
2.4 Addictions Therapeutics Segment by Application
  2.4.1 Public
  2.4.2 Private
  2.4.3 Government
2.5 Addictions Therapeutics Market Size by Application
  2.5.1 Addictions Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Addictions Therapeutics Market Size Market Share by Application (2020-2025)

3 ADDICTIONS THERAPEUTICS MARKET SIZE BY PLAYER

3.1 Addictions Therapeutics Market Size Market Share by Player
  3.1.1 Global Addictions Therapeutics Revenue by Player (2020-2025)
  3.1.2 Global Addictions Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global Addictions Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ADDICTIONS THERAPEUTICS BY REGION

4.1 Addictions Therapeutics Market Size by Region (2020-2025)
4.2 Global Addictions Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Addictions Therapeutics Market Size Growth (2020-2025)
4.4 APAC Addictions Therapeutics Market Size Growth (2020-2025)
4.5 Europe Addictions Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa Addictions Therapeutics Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Addictions Therapeutics Market Size by Country (2020-2025)
5.2 Americas Addictions Therapeutics Market Size by Type (2020-2025)
5.3 Americas Addictions Therapeutics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Addictions Therapeutics Market Size by Region (2020-2025)
6.2 APAC Addictions Therapeutics Market Size by Type (2020-2025)
6.3 APAC Addictions Therapeutics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Addictions Therapeutics Market Size by Country (2020-2025)
7.2 Europe Addictions Therapeutics Market Size by Type (2020-2025)
7.3 Europe Addictions Therapeutics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Addictions Therapeutics by Region (2020-2025)
8.2 Middle East & Africa Addictions Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa Addictions Therapeutics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL ADDICTIONS THERAPEUTICS MARKET FORECAST

10.1 Global Addictions Therapeutics Forecast by Region (2026-2031)
  10.1.1 Global Addictions Therapeutics Forecast by Region (2026-2031)
  10.1.2 Americas Addictions Therapeutics Forecast
  10.1.3 APAC Addictions Therapeutics Forecast
  10.1.4 Europe Addictions Therapeutics Forecast
  10.1.5 Middle East & Africa Addictions Therapeutics Forecast
10.2 Americas Addictions Therapeutics Forecast by Country (2026-2031)
  10.2.1 United States Market Addictions Therapeutics Forecast
  10.2.2 Canada Market Addictions Therapeutics Forecast
  10.2.3 Mexico Market Addictions Therapeutics Forecast
  10.2.4 Brazil Market Addictions Therapeutics Forecast
10.3 APAC Addictions Therapeutics Forecast by Region (2026-2031)
  10.3.1 China Addictions Therapeutics Market Forecast
  10.3.2 Japan Market Addictions Therapeutics Forecast
  10.3.3 Korea Market Addictions Therapeutics Forecast
  10.3.4 Southeast Asia Market Addictions Therapeutics Forecast
  10.3.5 India Market Addictions Therapeutics Forecast
  10.3.6 Australia Market Addictions Therapeutics Forecast
10.4 Europe Addictions Therapeutics Forecast by Country (2026-2031)
  10.4.1 Germany Market Addictions Therapeutics Forecast
  10.4.2 France Market Addictions Therapeutics Forecast
  10.4.3 UK Market Addictions Therapeutics Forecast
  10.4.4 Italy Market Addictions Therapeutics Forecast
  10.4.5 Russia Market Addictions Therapeutics Forecast
10.5 Middle East & Africa Addictions Therapeutics Forecast by Region (2026-2031)
  10.5.1 Egypt Market Addictions Therapeutics Forecast
  10.5.2 South Africa Market Addictions Therapeutics Forecast
  10.5.3 Israel Market Addictions Therapeutics Forecast
  10.5.4 Turkey Market Addictions Therapeutics Forecast
10.6 Global Addictions Therapeutics Forecast by Type (2026-2031)
10.7 Global Addictions Therapeutics Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Addictions Therapeutics Forecast

11 KEY PLAYERS ANALYSIS

11.1 Alkermes Plc
  11.1.1 Alkermes Plc Company Information
  11.1.2 Alkermes Plc Addictions Therapeutics Product Offered
  11.1.3 Alkermes Plc Addictions Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Alkermes Plc Main Business Overview
  11.1.5 Alkermes Plc Latest Developments
11.2 Amneal Pharmaceuticals Inc.
  11.2.1 Amneal Pharmaceuticals Inc. Company Information
  11.2.2 Amneal Pharmaceuticals Inc. Addictions Therapeutics Product Offered
  11.2.3 Amneal Pharmaceuticals Inc. Addictions Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Amneal Pharmaceuticals Inc. Main Business Overview
  11.2.5 Amneal Pharmaceuticals Inc. Latest Developments
11.3 Indivior Plc
  11.3.1 Indivior Plc Company Information
  11.3.2 Indivior Plc Addictions Therapeutics Product Offered
  11.3.3 Indivior Plc Addictions Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Indivior Plc Main Business Overview
  11.3.5 Indivior Plc Latest Developments
11.4 Johnson & Johnson Services Inc.
  11.4.1 Johnson & Johnson Services Inc. Company Information
  11.4.2 Johnson & Johnson Services Inc. Addictions Therapeutics Product Offered
  11.4.3 Johnson & Johnson Services Inc. Addictions Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Johnson & Johnson Services Inc. Main Business Overview
  11.4.5 Johnson & Johnson Services Inc. Latest Developments
11.5 Mylan NV
  11.5.1 Mylan NV Company Information
  11.5.2 Mylan NV Addictions Therapeutics Product Offered
  11.5.3 Mylan NV Addictions Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Mylan NV Main Business Overview
  11.5.5 Mylan NV Latest Developments
11.6 Novartis AG
  11.6.1 Novartis AG Company Information
  11.6.2 Novartis AG Addictions Therapeutics Product Offered
  11.6.3 Novartis AG Addictions Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Novartis AG Main Business Overview
  11.6.5 Novartis AG Latest Developments
11.7 Novo Nordisk AS
  11.7.1 Novo Nordisk AS Company Information
  11.7.2 Novo Nordisk AS Addictions Therapeutics Product Offered
  11.7.3 Novo Nordisk AS Addictions Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Novo Nordisk AS Main Business Overview
  11.7.5 Novo Nordisk AS Latest Developments
11.8 Opiant Pharmaceuticals Inc.
  11.8.1 Opiant Pharmaceuticals Inc. Company Information
  11.8.2 Opiant Pharmaceuticals Inc. Addictions Therapeutics Product Offered
  11.8.3 Opiant Pharmaceuticals Inc. Addictions Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Opiant Pharmaceuticals Inc. Main Business Overview
  11.8.5 Opiant Pharmaceuticals Inc. Latest Developments
11.9 Pfizer Inc.
  11.9.1 Pfizer Inc. Company Information
  11.9.2 Pfizer Inc. Addictions Therapeutics Product Offered
  11.9.3 Pfizer Inc. Addictions Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Pfizer Inc. Main Business Overview
  11.9.5 Pfizer Inc. Latest Developments
11.10 Teva Pharmaceutical Industries Ltd.
  11.10.1 Teva Pharmaceutical Industries Ltd. Company Information
  11.10.2 Teva Pharmaceutical Industries Ltd. Addictions Therapeutics Product Offered
  11.10.3 Teva Pharmaceutical Industries Ltd. Addictions Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
  11.10.5 Teva Pharmaceutical Industries Ltd. Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Addictions Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Addictions Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Alcohol Addiction Therapeutics
Table 4. Major Players of Tobacco Addiction Therapeutics
Table 5. Major Players of Drug Addiction Therapeutics
Table 6. Addictions Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Addictions Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Addictions Therapeutics Market Size Market Share by Type (2020-2025)
Table 9. Addictions Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Addictions Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Addictions Therapeutics Market Size Market Share by Application (2020-2025)
Table 12. Global Addictions Therapeutics Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Addictions Therapeutics Revenue Market Share by Player (2020-2025)
Table 14. Addictions Therapeutics Key Players Head office and Products Offered
Table 15. Addictions Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Addictions Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Addictions Therapeutics Market Size Market Share by Region (2020-2025)
Table 20. Global Addictions Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Addictions Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Addictions Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Addictions Therapeutics Market Size Market Share by Country (2020-2025)
Table 24. Americas Addictions Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Addictions Therapeutics Market Size Market Share by Type (2020-2025)
Table 26. Americas Addictions Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Addictions Therapeutics Market Size Market Share by Application (2020-2025)
Table 28. APAC Addictions Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Addictions Therapeutics Market Size Market Share by Region (2020-2025)
Table 30. APAC Addictions Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Addictions Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Addictions Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Addictions Therapeutics Market Size Market Share by Country (2020-2025)
Table 34. Europe Addictions Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Addictions Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Addictions Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Addictions Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Addictions Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Addictions Therapeutics
Table 40. Key Market Challenges & Risks of Addictions Therapeutics
Table 41. Key Industry Trends of Addictions Therapeutics
Table 42. Global Addictions Therapeutics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Addictions Therapeutics Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Addictions Therapeutics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Addictions Therapeutics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Alkermes Plc Details, Company Type, Addictions Therapeutics Area Served and Its Competitors
Table 47. Alkermes Plc Addictions Therapeutics Product Offered
Table 48. Alkermes Plc Addictions Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Alkermes Plc Main Business
Table 50. Alkermes Plc Latest Developments
Table 51. Amneal Pharmaceuticals Inc. Details, Company Type, Addictions Therapeutics Area Served and Its Competitors
Table 52. Amneal Pharmaceuticals Inc. Addictions Therapeutics Product Offered
Table 53. Amneal Pharmaceuticals Inc. Addictions Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Amneal Pharmaceuticals Inc. Main Business
Table 55. Amneal Pharmaceuticals Inc. Latest Developments
Table 56. Indivior Plc Details, Company Type, Addictions Therapeutics Area Served and Its Competitors
Table 57. Indivior Plc Addictions Therapeutics Product Offered
Table 58. Indivior Plc Addictions Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Indivior Plc Main Business
Table 60. Indivior Plc Latest Developments
Table 61. Johnson & Johnson Services Inc. Details, Company Type, Addictions Therapeutics Area Served and Its Competitors
Table 62. Johnson & Johnson Services Inc. Addictions Therapeutics Product Offered
Table 63. Johnson & Johnson Services Inc. Addictions Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Johnson & Johnson Services Inc. Main Business
Table 65. Johnson & Johnson Services Inc. Latest Developments
Table 66. Mylan NV Details, Company Type, Addictions Therapeutics Area Served and Its Competitors
Table 67. Mylan NV Addictions Therapeutics Product Offered
Table 68. Mylan NV Addictions Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Mylan NV Main Business
Table 70. Mylan NV Latest Developments
Table 71. Novartis AG Details, Company Type, Addictions Therapeutics Area Served and Its Competitors
Table 72. Novartis AG Addictions Therapeutics Product Offered
Table 73. Novartis AG Addictions Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Novartis AG Main Business
Table 75. Novartis AG Latest Developments
Table 76. Novo Nordisk AS Details, Company Type, Addictions Therapeutics Area Served and Its Competitors
Table 77. Novo Nordisk AS Addictions Therapeutics Product Offered
Table 78. Novo Nordisk AS Addictions Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Novo Nordisk AS Main Business
Table 80. Novo Nordisk AS Latest Developments
Table 81. Opiant Pharmaceuticals Inc. Details, Company Type, Addictions Therapeutics Area Served and Its Competitors
Table 82. Opiant Pharmaceuticals Inc. Addictions Therapeutics Product Offered
Table 83. Opiant Pharmaceuticals Inc. Addictions Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Opiant Pharmaceuticals Inc. Main Business
Table 85. Opiant Pharmaceuticals Inc. Latest Developments
Table 86. Pfizer Inc. Details, Company Type, Addictions Therapeutics Area Served and Its Competitors
Table 87. Pfizer Inc. Addictions Therapeutics Product Offered
Table 88. Pfizer Inc. Addictions Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Pfizer Inc. Main Business
Table 90. Pfizer Inc. Latest Developments
Table 91. Teva Pharmaceutical Industries Ltd. Details, Company Type, Addictions Therapeutics Area Served and Its Competitors
Table 92. Teva Pharmaceutical Industries Ltd. Addictions Therapeutics Product Offered
Table 93. Teva Pharmaceutical Industries Ltd. Addictions Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Teva Pharmaceutical Industries Ltd. Main Business
Table 95. Teva Pharmaceutical Industries Ltd. Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Addictions Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Addictions Therapeutics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Addictions Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Addictions Therapeutics Sales Market Share by Country/Region (2024)
Figure 8. Addictions Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Addictions Therapeutics Market Size Market Share by Type in 2024
Figure 10. Addictions Therapeutics in Public
Figure 11. Global Addictions Therapeutics Market: Public (2020-2025) & ($ millions)
Figure 12. Addictions Therapeutics in Private
Figure 13. Global Addictions Therapeutics Market: Private (2020-2025) & ($ millions)
Figure 14. Addictions Therapeutics in Government
Figure 15. Global Addictions Therapeutics Market: Government (2020-2025) & ($ millions)
Figure 16. Global Addictions Therapeutics Market Size Market Share by Application in 2024
Figure 17. Global Addictions Therapeutics Revenue Market Share by Player in 2024
Figure 18. Global Addictions Therapeutics Market Size Market Share by Region (2020-2025)
Figure 19. Americas Addictions Therapeutics Market Size 2020-2025 ($ millions)
Figure 20. APAC Addictions Therapeutics Market Size 2020-2025 ($ millions)
Figure 21. Europe Addictions Therapeutics Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Addictions Therapeutics Market Size 2020-2025 ($ millions)
Figure 23. Americas Addictions Therapeutics Value Market Share by Country in 2024
Figure 24. United States Addictions Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Addictions Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Addictions Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Addictions Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Addictions Therapeutics Market Size Market Share by Region in 2024
Figure 29. APAC Addictions Therapeutics Market Size Market Share by Type (2020-2025)
Figure 30. APAC Addictions Therapeutics Market Size Market Share by Application (2020-2025)
Figure 31. China Addictions Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Addictions Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Addictions Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Addictions Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 35. India Addictions Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Addictions Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Addictions Therapeutics Market Size Market Share by Country in 2024
Figure 38. Europe Addictions Therapeutics Market Size Market Share by Type (2020-2025)
Figure 39. Europe Addictions Therapeutics Market Size Market Share by Application (2020-2025)
Figure 40. Germany Addictions Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 41. France Addictions Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Addictions Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Addictions Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Addictions Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Addictions Therapeutics Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Addictions Therapeutics Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Addictions Therapeutics Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Addictions Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Addictions Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Addictions Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Addictions Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Addictions Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Addictions Therapeutics Market Size 2026-2031 ($ millions)
Figure 54. APAC Addictions Therapeutics Market Size 2026-2031 ($ millions)
Figure 55. Europe Addictions Therapeutics Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Addictions Therapeutics Market Size 2026-2031 ($ millions)
Figure 57. United States Addictions Therapeutics Market Size 2026-2031 ($ millions)
Figure 58. Canada Addictions Therapeutics Market Size 2026-2031 ($ millions)
Figure 59. Mexico Addictions Therapeutics Market Size 2026-2031 ($ millions)
Figure 60. Brazil Addictions Therapeutics Market Size 2026-2031 ($ millions)
Figure 61. China Addictions Therapeutics Market Size 2026-2031 ($ millions)
Figure 62. Japan Addictions Therapeutics Market Size 2026-2031 ($ millions)
Figure 63. Korea Addictions Therapeutics Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Addictions Therapeutics Market Size 2026-2031 ($ millions)
Figure 65. India Addictions Therapeutics Market Size 2026-2031 ($ millions)
Figure 66. Australia Addictions Therapeutics Market Size 2026-2031 ($ millions)
Figure 67. Germany Addictions Therapeutics Market Size 2026-2031 ($ millions)
Figure 68. France Addictions Therapeutics Market Size 2026-2031 ($ millions)
Figure 69. UK Addictions Therapeutics Market Size 2026-2031 ($ millions)
Figure 70. Italy Addictions Therapeutics Market Size 2026-2031 ($ millions)
Figure 71. Russia Addictions Therapeutics Market Size 2026-2031 ($ millions)
Figure 72. Egypt Addictions Therapeutics Market Size 2026-2031 ($ millions)
Figure 73. South Africa Addictions Therapeutics Market Size 2026-2031 ($ millions)
Figure 74. Israel Addictions Therapeutics Market Size 2026-2031 ($ millions)
Figure 75. Turkey Addictions Therapeutics Market Size 2026-2031 ($ millions)
Figure 76. Global Addictions Therapeutics Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Addictions Therapeutics Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Addictions Therapeutics Market Size 2026-2031 ($ millions)